Author: Dr. Joanna Barbara
Ask Me Anything About In Vitro ADME, Drug-Drug Interaction Approaches and Strategies
- ADME 101™
- December 1, 2022
- Dr. Joanna Barbara
Last month, Dr. Joanna Barbara joined AAPS for an online Q&A in their ongoing “Ask the Experts” series. As regulatory...
In Vitro Evaluation of Drug-Drug Interaction (DDI) Potential
- Enzyme Inhibition
- March 24, 2020
- Madison Esely-Kohlman, Zachary Mitts, Dr. Joanna Barbara
In its most recent in vitro drug interaction guidance update, the US Food and Drug Administration (FDA) emphasized harmony with the...
How can in vitro and in vivo studies help me understand my drug’s clearance?
- Regulatory Guidance
- March 5, 2020
- Madison Esely-Kohlman, Dr. Joanna Barbara
Systemic clearance, denoting how much drug is cleared from a volume of blood per unit of time, is of critical...
In Vitro Induction Studies: Elements of Design and Important Considerations in Data Analysis
- Enzyme Induction
- May 13, 2019
- Madison Esely-Kohlman, Dr. Joanna Barbara, Rebecca Campbell
Why do induction studies? Induction potential is an important piece of the drug-drug interaction (DDI) component of an IND submission. Simply put, we...
Minding Your Binding: Plasma Protein Binding Potential Study Now Available at Our US Labs
- Test Systems & Methods
- April 15, 2019
- Madison Esely-Kohlman, Andrea Wolff, Dr. Joanna Barbara
While liver and intestine are important in ADME, behavior in blood is also crucial. When an orally administered drug or...
Challenges & Solutions in Today’s In Vitro Transporter Research
- Drug Transporters
- August 30, 2018
- Michael Millhollen, Dr. Joanna Barbara
Transporters are membrane-bound proteins that govern the passage of drugs into and out of cells. These gatekeeper proteins can be...
Subscribe to our Newsletter
Stay up to date with our news, events and research
Do you have a question or a request for upcoming blog content?
We love to get your feedback